연구성과로 돌아가기
JCR 2024 저널 목록 (1121 / 2104)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Journal Name | Publisher | ISSN | eISSN | Edition | WoS Category | Total Citation | JIF | JIF Quartile | 상위 JCR(%) | JIF % | JIF Rank | 5-Year JIF | 5-Year Quartile | JIF w/o Self-Cites | Immediacy Index | JCI | JCI Rank | JCI Quartile | JCI Percentile | Eigenfactor Score | Normalized Eigenfactor | Article Influence Score | AIS Quartile | Citable Items | Articles in Citable Items (%) | Cited Half-Life | Citing Half-Life | Total Articles | Citable OA (%) | 수집시기 | 바로가기 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Risks | MDPI | N/A | 2227-9091 | ESCI | BUSINESS, FINANCE | 1,890 | 1.5 | Q3 | 57.1 | 42.9 | 138/241 | 1.7 | Q3 | 1.4 | 0.3 | 0.54 | 120/241 | Q2 | 50.41 | 0.002 | 0.503 | 0.308 | Q3 | 203 | 96.1% | 3.4 | 7.3 | 195 | 100.0% | 2025-08-05 16:02:35 | 바로가기 |
| ACTA CYTOLOGICA | KARGER | 0001-5547 | 1938-2650 | SCIE | PATHOLOGY | 2,045 | 1.7 | Q3 | 57.2 | 42.8 | 52/90 | 2.1 | Q3 | 1.5 | 0.2 | 0.63 | 52/90 | Q3 | 42.78 | 0.001 | 0.296 | 0.555 | Q3 | 63 | 82.5% | 11.0 | 8.3 | 52 | 12.9% | 2025-08-05 16:04:31 | 바로가기 |
| AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY | OXFORD UNIV PRESS INC | 1079-2082 | 1535-2900 | SCIE | PHARMACOLOGY & PHARMACY | 6,591 | 2.3 | Q3 | 57.2 | 42.8 | 202/352 | 2.6 | Q3 | 1.8 | 0.5 | 0.49 | 237/353 | Q3 | 33.00 | 0.005 | 1.048 | 0.619 | Q2 | 247 | 89.1% | 7.9 | 6.4 | 220 | 8.7% | 2025-08-05 16:04:34 | 바로가기 |
| ANNALS OF PHARMACOTHERAPY | SAGE PUBLICATIONS INC | 1060-0280 | 1542-6270 | SCIE | PHARMACOLOGY & PHARMACY | 7,003 | 2.3 | Q3 | 57.2 | 42.8 | 202/352 | 2.7 | Q3 | 2.3 | 0.4 | 0.48 | 244/353 | Q3 | 31.02 | 0.005 | 1.048 | 0.774 | Q2 | 92 | 62.0% | 11.3 | 6.0 | 57 | 2.2% | 2025-08-05 16:04:33 | 바로가기 |
| ANTIVIRAL THERAPY | SAGE PUBLICATIONS LTD | 1359-6535 | 2040-2058 | SCIE | PHARMACOLOGY & PHARMACY | 1,590 | 2.3 | Q3 | 57.2 | 42.8 | 202/352 | 1.7 | Q4 | 2.3 | 0.3 | 0.41 | 266/353 | Q4 | 24.79 | 0.001 | 0.184 | 0.549 | Q3 | 11 | 100.0% | 11.7 | 4.7 | 11 | 92.9% | 2025-08-05 16:04:35 | 바로가기 |
| CANCER CHEMOTHERAPY AND PHARMACOLOGY | SPRINGER | 0344-5704 | 1432-0843 | SCIE | PHARMACOLOGY & PHARMACY | 9,031 | 2.3 | Q3 | 57.2 | 42.8 | 202/352 | 2.5 | Q3 | 2.3 | 0.5 | 0.64 | 185/353 | Q3 | 47.73 | 0.004 | 0.944 | 0.619 | Q2 | 88 | 92.0% | 10.1 | 7.8 | 81 | 33.1% | 2025-08-05 16:04:33 | 바로가기 |
| Clinical Pathology | SAGE PUBLICATIONS LTD | 2632-010X | 2632-010X | ESCI | PATHOLOGY | 192 | 1.7 | Q3 | 57.2 | 42.8 | 52/90 | 1.3 | Q3 | 1.7 | 0.7 | 0.63 | 52/90 | Q3 | 42.78 | 0.000 | 0.092 | 0.416 | Q3 | 29 | 93.1% | 2.4 | 4.9 | 27 | 94.8% | 2025-08-05 16:04:31 | 바로가기 |
| Engineering Management Journal | TAYLOR & FRANCIS LTD | 1042-9247 | 2377-0643 | SCIE | ENGINEERING, INDUSTRIAL | 882 | 2.6 | Q3 | 57.2 | 42.8 | 40/69 | 2.6 | Q3 | 2.3 | 0.2 | 0.39 | 45/69 | Q3 | 35.51 | 0.000 | 0.092 | 0.347 | Q3 | 39 | 97.4% | 6.6 | 6.9 | 38 | 5.5% | 2025-08-05 16:03:09 | 바로가기 |
| INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY | LIPPINCOTT WILLIAMS & WILKINS | 0277-1691 | 1538-7151 | SCIE | PATHOLOGY | 3,007 | 1.7 | Q3 | 57.2 | 42.8 | 52/90 | 2.3 | Q2 | 1.6 | 1.0 | 0.79 | 40/90 | Q2 | 56.11 | 0.002 | 0.554 | 0.683 | Q2 | 73 | 98.6% | 9.0 | 7.5 | 72 | 4.7% | 2025-08-05 16:04:30 | 바로가기 |
| JOURNAL OF CLINICAL PHARMACOLOGY | WILEY | 0091-2700 | 1552-4604 | SCIE | PHARMACOLOGY & PHARMACY | 7,626 | 2.3 | Q3 | 57.2 | 42.8 | 202/352 | 2.6 | Q3 | 2.2 | 0.6 | 0.66 | 177/353 | Q3 | 50.00 | 0.006 | 1.236 | 0.794 | Q2 | 155 | 92.3% | 9.9 | 8.5 | 143 | 30.0% | 2025-08-05 16:04:33 | 바로가기 |
| Journal of Dietary Supplements | TAYLOR & FRANCIS LTD | 1939-0211 | 1939-022X | ESCI | PHARMACOLOGY & PHARMACY | 1,421 | 2.3 | Q3 | 57.2 | 42.8 | 202/352 | 2.8 | Q2 | 2.2 | 0.9 | 0.53 | 221/353 | Q3 | 37.54 | 0.001 | 0.240 | 0.493 | Q3 | 34 | 61.8% | 5.2 | 8.0 | 21 | 24.5% | 2025-08-05 16:04:35 | 바로가기 |
| Pharmacology Research & Perspectives | JOHN WILEY & SONS LTD | 2052-1707 | 2052-1707 | SCIE | PHARMACOLOGY & PHARMACY | 2,665 | 2.3 | Q3 | 57.2 | 42.8 | 202/352 | 2.8 | Q2 | 2.3 | 0.6 | 0.70 | 158/353 | Q2 | 55.38 | 0.004 | 0.797 | 0.712 | Q2 | 124 | 80.6% | 4.3 | 7.8 | 100 | 82.7% | 2025-08-05 16:04:34 | 바로가기 |
| URBAN EDUCATION | SAGE PUBLICATIONS INC | 0042-0859 | 1552-8340 | SSCI | URBAN STUDIES | 3,124 | 1.7 | Q3 | 57.2 | 42.8 | 44/76 | 2.6 | Q2 | 1.4 | 0.4 | 0.87 | 17/77 | Q1 | 78.57 | 0.004 | 0.810 | 0.978 | Q2 | 50 | 100.0% | 7.6 | 9.1 | 50 | 7.7% | 2025-08-05 16:05:29 | 바로가기 |
| Urban Planning | COGITATIO PRESS | 2183-7635 | 2183-7635 | ESCI | URBAN STUDIES | 1,615 | 1.7 | Q3 | 57.2 | 42.8 | 44/76 | 2.2 | Q3 | 1.6 | 0.7 | 0.51 | 43/77 | Q3 | 44.81 | 0.002 | 0.481 | 0.536 | Q3 | 126 | 98.4% | 4.2 | 7.4 | 124 | 98.4% | 2025-08-05 16:05:29 | 바로가기 |
| Urban Policy and Research | ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD | 0811-1146 | 1476-7244 | SSCI | URBAN STUDIES | 869 | 1.7 | Q3 | 57.2 | 42.8 | 44/76 | N/A | N/A | 1.7 | 0.2 | 0.42 | 52/77 | Q3 | 33.12 | 0.001 | 0.118 | N/A | N/A | 33 | 60.6% | 9.0 | 7.0 | 20 | 42.2% | 2025-08-05 16:05:29 | 바로가기 |
페이지 이동: